Michael McCaughan, co-founder of Provision Policy, spoke about drug pricing policy at the 340B Coalition Winter Conference.

Potential Senate Flip May Increase 340B Scrutiny, But Congressional 340B Action Unlikely in 2024, Say 340B Advocate, Drug Industry Analyst

February 1, 2024 William Newton, Associate Editor/Senior Writer Views

Congress is unlikely to act on 340B in 2024, but a potential flip of the U.S. Senate could lead to [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!